BIONTECH SE - AMERICAN DEPOSITARY SHARES

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

08 9 2025 08:00:00 提供 Nasdaq GlobeNewswire

Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

27 8 2025 09:50:00 提供 Nasdaq GlobeNewswire

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

04 8 2025 03:45:00 提供 Nasdaq GlobeNewswire

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

24 7 2025 23:30:00 提供 Nasdaq GlobeNewswire

BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025

21 7 2025 03:45:00 提供 Nasdaq GlobeNewswire

BioNTech Announces Ryan Richardson to Step Down from the Management Board

17 7 2025 05:30:00 提供 Nasdaq GlobeNewswire

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

12 6 2025 03:44:59 提供 Nasdaq GlobeNewswire

BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types

02 6 2025 03:45:00 提供 Nasdaq GlobeNewswire

BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting

27 5 2025 05:15:00 提供 Nasdaq GlobeNewswire

BioNTech Announces First Quarter 2025 Financial Results and Corporate Update

05 5 2025 03:45:00 提供 Nasdaq GlobeNewswire

BioNTech Announces Appointment of Ramón Zapata to Management Board as Chief Financial Officer

05 5 2025 03:30:00 提供 Nasdaq GlobeNewswire

BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025

24 4 2025 03:45:00 提供 Nasdaq GlobeNewswire

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025

22 4 2025 03:45:00 提供 Nasdaq GlobeNewswire

BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update

10 3 2025 03:55:00 提供 Nasdaq GlobeNewswire

BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025

24 2 2025 03:45:00 提供 Nasdaq GlobeNewswire

BioNTech Completes Acquisition of Biotheus

03 2 2025 03:45:00 提供 Nasdaq GlobeNewswire

BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference

14 1 2025 03:45:00 提供 Nasdaq GlobeNewswire

BioNTech to Acquire Biotheus to Boost Oncology Strategy

13 11 2024 03:45:00 提供 Nasdaq GlobeNewswire

BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update

04 11 2024 03:45:00 提供 Nasdaq GlobeNewswire

BioNTech to Host Innovation Series R&D Day on November 14, 2024

31 10 2024 04:45:00 提供 Nasdaq GlobeNewswire